ProAxsis collaboration highlighted as success story by the Medical Research Council

Date : December 09, 2015

ProAxsis is delighted to announce that it has been highlighted as a success story in the 2014/15 Outputs, outcomes and impact of Medical Research Council (MRC) research report.

The MRC aims to improve human health through world-class medical research by funding research across the biomedical spectrum, from fundamental lab-based science to clinical trials, in all major disease areas.

ProAxsis’ co-founders, Professor Brian Walker and Dr Lorraine Martin were awarded the MRC Confidence in Concept grant, and it was used to support the development of the company’s unique ProteaseTag™ technology which can selectively detect and bind to proteases, including those which are disease biomarkers such as Neutrophil Elastase.

“Taking in to account the vast array of pharmaceutical, medical and scientific companies that collaborate with the MRC, to be selected as one of their top success stories during 2014/15 is a fantastic endorsement of what we’re working to achieve at ProAxsis”, said Dr David Ribeiro, CEO of ProAxsis.

The chapter of the report entitled “Industry interactions and other collaborations” is now available on the MRC website. The full report is expected to be published in early 2016.

ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies.